Neoadjuvant Radiotherapy Versus No Radiotherapy for Stage IV Rectal Cancer: a Systematic Review and Meta-analysis.
Ryan Anthony F AgasLester Bryan A CoJ C Kennetth M JacintoKelvin Ken L YuPaolo G SogonoWarren R BacorroTeresa T Sy OrtinPublished in: Journal of gastrointestinal cancer (2019)
The current available evidence shows an LRFS benefit with NRT over no RT in patients with stage IV rectal cancer. The review also suggests a possible OS benefit with NRT, although this finding should be interpreted with caution.